Alnylam Pharmaceuticals Aktie
248,00
EUR
-0,70
EUR
-0,28
%
268,35
USD
-2,49
USD
-0,92
%
Werbung
Alnylam Pharmaceuticals Aktie Analyse
20.08.08 | Alnylam Pharmaceuticals underperform | Leerink Swann LLC | |
03.03.08 | Alnylam Pharmaceuticals underperform | Needham & Company, LLC |
Werbung
Werbung